Please use this identifier to cite or link to this item: http://hdl.handle.net/11189/8698
Title: Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells
Authors: Ebokaiwe, Azubuike Peter 
Njoya, Emmanuel Mfotie 
Sheng, Yuwen 
Zhang, Zhonghui 
Li, Sheng 
Zhou, Zongyuan 
Qiang, Zhe 
Peng, Ting 
Hussein, Ahmed A. 
Zhang, Guolin 
Lu, Xiaoxia 
Li, Lin 
Wang, Fei 
Keywords: Indoleamine-2,3-Dioxygenase;Kynurenine;Salinomycin;Interferon γ;Breast cancer
Issue Date: 2020
Publisher: Elsevier
Source: Ebokaiwe, A.P., Njoya, E.M., Sheng, Y. et al. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells. Toxicology and Applied Pharmacology, 404: 1-12. [https://doi.org/10.1016/j.taap.2020.115203]
Journal: Toxicology and Applied Pharmacology 
Abstract: Indoleamine 2,3 dioxygenase (IDO) is upregulated in many tumor types, including breast cancer, and plays a reputable role in promoting tumor immune tolerance. The importance of the immunosuppressive mechanism of IDO by suppressing T-cell function has garnered profound interest in the development of clinical IDO inhibitors. Herein, we established a screening method with cervical HeLa cells to induce IDO expression using interferon-γ (IFN-γ). After screening our chemical library, we found that salinomycin potently inhibited IFN-γ-stimulated kynurenine synthesis with IC50 values of 3.36–4.66 μM in both human cervical and breast cancer cells. Salinomycin lowered the IDO1 and IDO2 expression with no impact on the expression of tryptophan-2,3-dioxygenase. Interestingly, salinomycin potently repressed the IDO1 enzymatic activity by directly targeting the proteins in cells. Molecular docking revealed an alignment that favors nucleophilic attack of salinomycin in the catalytic domain of IDO1. Activation of the Janus kinase/signal transducer and activator of transcription (JAK/ STAT) pathway by IFN-γ was significantly suppressed by salinomycin, via inhibiting the Jak1, Jak2, and STAT1/ 3 phosphorylation. Moreover, it inhibited IFN-γ-induced activation of the nuclear factor (NF)-κB pathway by inhibiting IκB degradation and NF-κB phosphorylation without affecting BIN1 expression. Furthermore, salinomycin significantly restored the proliferation of T cells co-cultured with IFN-γ-treated breast cancer cells and potentiated antitumor activity of cisplatin in vivo. These findings suggest that salinomycin suppresses kynurenine synthesis by inhibiting the catalytic activity of IDO1 and its expression by inhibiting the JAK/STAT and NF-κB pathways. Salinomycin warrants further investigation as a novel dual-functional IDO inhibitor for cancer immunotherapy.
URI: http://hdl.handle.net/11189/8698
ISSN: 0041-008X
DOI: https://doi.org/10.1016/j.taap.2020.115203
Appears in Collections:Appsc - Journal Articles (DHET subsidised)

Files in This Item:
File Description SizeFormat 
Salinomycin_promotes_T-cell_proliferation.pdf3.17 MBAdobe PDFView/Open
Show full item record

Page view(s)

97
Last Week
0
Last month
6
checked on Aug 12, 2026

Download(s)

52
checked on Aug 12, 2026

Google ScholarTM

Check

Altmetric


Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.